LOCOID LIPOCREAM (hydrocortisone butyrate) by Precision BioSciences is signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in atopic dermatitis is unknown. First approved in 1997.
Drug data last refreshed 26m ago · AI intelligence enriched 1w ago
LOCOID LIPOCREAM is a topical corticosteroid cream containing hydrocortisone butyrate, used to treat inflammatory skin conditions including atopic dermatitis. The drug works through immune signaling modulation and protein regulation, though its precise mechanism in atopic dermatitis remains incompletely understood. It is administered as a cream applied directly to affected skin areas.
Product is in late-stage lifecycle approaching loss of exclusivity, signaling a smaller, consolidating commercial team focused on defending market share against generics.
signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in atopic dermatitis is unknown.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on LOCOID LIPOCREAM offers limited growth opportunities given the LOE-approaching lifecycle and zero linked job count, suggesting a small, consolidating team. Career value lies in gaining experience in generic defense, market maintenance, and cost optimization rather than launching or growing a product.
Worked on LOCOID LIPOCREAM at Precision BioSciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo